{"id":1068153,"date":"2021-02-15T03:13:36","date_gmt":"2021-02-15T08:13:36","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/biophytis-announces-closing-of-ads-offering-on-nasdaq-capital-market\/"},"modified":"2024-08-18T11:43:36","modified_gmt":"2024-08-18T15:43:36","slug":"biophytis-announces-closing-of-ads-offering-on-nasdaq-capital-market","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biophytis-announces-closing-of-ads-offering-on-nasdaq-capital-market.php","title":{"rendered":"Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market"},"content":{"rendered":"<p><![CDATA[PARIS and CAMBRIDGE, Mass., Feb.  15, 2021  (GLOBE NEWSWIRE) -- Biophytis (NasdaqCM: BPTS; Euronext Growth Paris: ALBPS) (\u201cBiophytis\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces the closing of its previously announced initial public offering on the Nasdaq Capital Market by way of a capital increase of 12,000,000 new ordinary shares represented by 1,200,000 American Depositary Shares (\u201cADSs\u201d), with each ADS representing 10 ordinary shares, at an offering price of $16.75 per ADS (the \u201cOffering\u201d).]]><\/p>\n<p>Read more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/02\/15\/2175249\/0\/en\/Biophytis-Announces-Closing-of-ADS-Offering-on-Nasdaq-Capital-Market.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market\">Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more here: Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/biophytis-announces-closing-of-ads-offering-on-nasdaq-capital-market.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068153","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068153"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068153"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068153\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}